These properties are consistent with those reported for a number of other hormone-resistant breast cancer lines, where resistance to inhibitors of the mTOR/Akt pathway is generally associated with increased resistance to a broad variety of cytotoxic agents (21). Here, AKT1 is linked to breast cancer.